Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Stock Trading Ideas

Alphabet Stock Offers Exposure To SpaceX, Anthropic Before IPOs: What That Means For Investors
Alphabet Stock Offers Exposure To SpaceX, Anthropic Before IPOs: What That Means For Investors
SMCI, Dell Catch A Bid After Hours As HPE Stock Soars After Q2 Report
SMCI, Dell Catch A Bid After Hours As HPE Stock Soars After Q2 Report
Alphabet Stock Slides On AI-Fueled Capital Raise That Includes Additional Berkshire Investment
Alphabet Stock Slides On AI-Fueled Capital Raise That Includes Additional Berkshire Investment
SMCI, Dell Catch A Bid After Hours As HPE Stock Soars After Q2 Report
SMCI, Dell Catch A Bid After Hours As HPE Stock Soars After Q2 Report
Alphabet Stock Slides On AI-Fueled Capital Raise That Includes Additional Berkshire Investment
Alphabet Stock Slides On AI-Fueled Capital Raise That Includes Additional Berkshire Investment
Hewlett Packard Enterprise Stock Skyrockets After Q2 Earnings — Here's Why
Hewlett Packard Enterprise Stock Skyrockets After Q2 Earnings — Here's Why
Credo Technology Group Stock Dives Despite Q4 Earnings Beat
Credo Technology Group Stock Dives Despite Q4 Earnings Beat

Trading Ideas Recent News

Congressman Looking For Dividends? Taylor Ditches 2 Magnificent Seven Stocks For Blue Chips
Congressman Looking For Dividends? Taylor Ditches 2 Magnificent Seven Stocks For Blue Chips
A congressman ditches some Magnificent Seven stocks to buy some blue-chip, high dividend yield stocks.
Microchip Technology Stock Climbs On Data Center Revenue Growth
Microchip Technology Stock Climbs On Data Center Revenue Growth
Microchip Technology's stock climbs after the company reports Data Center Solutions Business Unit revenue and issues guidance for the segment.
FICO Just Put BNPL Loans Into Credit Scores: Who Sells The Data And Who Becomes The Data
FICO Just Put BNPL Loans Into Credit Scores: Who Sells The Data And Who Becomes The Data
Penguin Stock Is Moving Today — Here's What The Chart Is Signaling
Penguin Stock Is Moving Today — Here's What The Chart Is Signaling
Penguin Solutions shares are up Monday on AI and server‑infrastructure momentum, pressing fresh highs as Nasdaq gains 0.78% and S&P 500 0.41%.
The Trade Desk Stock Is On The Move: The Chart Tells An Interesting Story
The Trade Desk Stock Is On The Move: The Chart Tells An Interesting Story
Trade Desk is rising Monday as traders rotate back into higher‑beta tech after a year-long slide, with Nasdaq up 0.81% and S&P 500 up 0.41%.
TSMC's Price Hike Is Bad For Nvidia Margins — And Potentially Great For Nvidia Stock
TSMC's Price Hike Is Bad For Nvidia Margins — And Potentially Great For Nvidia Stock
TSMC is reportedly considering a 15% increase in 3nm chip prices in 2026 and a further hike in 2027. While higher costs could pressure Nvidia margins, the move may signal AI demand remains stronger than supply.
Anthropic's IPO Could Create A Problem For SpaceX
Anthropic's IPO Could Create A Problem For SpaceX
Anthropic has confidentially filed for an IPO just days after SpaceX's S-1. The AI startup's public-market ambitions could spark a battle for investor attention and growth capital.
BlackSky Stock Drops After Jefferies Downgrade to Hold
BlackSky Stock Drops After Jefferies Downgrade to Hold
BlackSky Technology shares are trading lower Monday after Jefferies downgraded the stock from Buy to Hold and reaffirmed a $50 price target.
5 IPOs To Watch This Week — And What They Signal Ahead Of SpaceX And Anthropic
5 IPOs To Watch This Week — And What They Signal Ahead Of SpaceX And Anthropic
A look at five initial public offerings (IPOs) that could price this week and come from several of the hottest themes.
Why Is Jade Biosciences Stock Trading Lower On Monday?
Why Is Jade Biosciences Stock Trading Lower On Monday?
Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations.
AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial
AstraZeneca Sees Encouraging Survival Trend In Liver Cancer Trial
AstraZeneca's EMERALD-3 trial shows improved progression-free survival with STRIDE, lenvatinib and TACE in liver cancer.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved